Global Leaders Urged to Finalize Pandemic Accord’s Crucial Pathogen-Sharing Mechanism

In a concerted and urgent appeal, Brazilian President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have called upon leaders of the G7, G20, BRICS nations, and all countries to conclude negotiations on the vital Pathogen Access and Benefit-Sharing (PABS) annex to the WHO Pandemic Agreement. With a critical deadline set for July 17, the two leaders emphasize that finalizing this annex is paramount to strengthening global defenses against future pandemics, fulfilling a promise made in the wake of the devastating COVID-19 crisis.

The Genesis of the Pandemic Accord: A World Scarred and United

The collective memory of the COVID-19 pandemic serves as the grim backdrop to this urgent plea. The disease, which emerged in late 2019, rapidly overwhelmed healthcare systems worldwide, leading to unprecedented levels of suffering and loss. Families were separated from loved ones, often forced to say their final goodbyes through glass barriers or over the phone. Frontline healthcare workers endured unimaginable strain, pushing themselves to the brink. Estimates from the WHO and other organizations place the global death toll at up to twenty million, a staggering figure that underscores the profound human cost. Beyond the immediate health crisis, the pandemic inflicted severe economic damage, with the International Monetary Fund (IMF) estimating a loss of over thirteen trillion dollars in global output, affecting every nation through shuttered businesses, broken supply chains, and widespread disruption to education.

In the crucible of this shared grief and disruption, humanity made a solemn promise: to never again face such a global health threat unprepared. This commitment led to the initiation of an ambitious effort to forge a new international instrument. After intense negotiations, the world delivered on the first part of that promise a little over a year ago. Against a backdrop of geopolitical division, nations chose cooperation over fragmentation, adopting the WHO Pandemic Agreement. This landmark accord aimed to establish a robust framework for countries to work together more effectively in preventing, preparing for, and responding to future pandemics. Its adoption was celebrated as an act of hope and faith in multilateralism, demonstrating that global challenges could be met with collective action.

The Critical Role of the Pathogen Access and Benefit-Sharing (PABS) Annex

Despite the significant achievement of the Pandemic Agreement’s adoption, its full operationalization hinges on the finalization of one crucial component: the Pathogen Access and Benefit-Sharing (PABS) annex. This annex is designed to be the backbone of a rapid and equitable global response system. Its core function is to ensure that countries can swiftly identify pathogens with pandemic potential and share their genetic information and material without delay. This sharing is indispensable for scientists worldwide to develop essential tools: diagnostic tests, life-saving treatments, and effective vaccines that ultimately determine survival rates during an outbreak.

The PABS system is founded on a principle of a "simple, fair bargain": nations that promptly share dangerous pathogens must be assured that the resulting vaccines, treatments, and other countermeasures born from that sharing will be accessible to their own populations. This mechanism is intended to replace the often ad-hoc and crisis-driven approaches seen during COVID-19, which frequently led to inequities in access and distribution. Without the PABS annex, the Pandemic Agreement cannot formally enter into force, leaving the global promise of enhanced preparedness unfulfilled.

Chronology of Negotiations and Sticking Points

The path to finalizing the PABS annex has been fraught with complexity. The Intergovernmental Negotiating Body (INB), established by the World Health Assembly, has been at the forefront of these discussions, bringing together representatives from WHO Member States. Over multiple sessions, negotiators have grappled with some of the most challenging questions related to global health equity and sovereignty.

• December 2021: The World Health Assembly agreed to launch a global process to draft and negotiate a new convention, agreement, or other international instrument under the Constitution of the WHO to strengthen pandemic prevention, preparedness, and response.
• February 2022: The INB held its first meeting, initiating the drafting process.
• May 2023: The World Health Assembly adopted the WHO Pandemic Agreement, signaling a major step forward, but acknowledged that the PABS annex required further dedicated negotiation.
• May 1, 2024: The most recent session of Member States concluded, having made tangible progress but ultimately agreeing that more time was needed to resolve outstanding issues. The discussions highlighted persistent divergences on how the benefits derived from shared pathogens should be defined and distributed, how the system itself would be governed, and the precise mechanisms to guarantee equity on an equal footing for all nations. These are not merely technical details; they represent the very questions that remained unanswered during the height of the COVID-19 pandemic, contributing to the tragic disparity in protection among populations.

Negotiators are scheduled to reconvene from July 6 to 17, 2024, for what is intended to be the decisive round of talks. President Lula and Dr. Tedros acknowledge the dedication of these negotiators but emphasize that this moment transcends technical discussions, requiring decisive leadership at the highest political levels.

A Call to Action: Three Key Demands

The joint appeal from President Lula and Dr. Tedros articulates three critical requests to global leaders:

1. Political Will at the Highest Level: The remaining impediments to the PABS annex cannot be overcome by technical efforts alone. Leaders are urged to provide a clear signal that finalizing this annex is a national priority, empowering their negotiators to pursue consensus with courage rather than caution. The letter stresses that "solidarity is our best immunity," but such solidarity must be a conscious choice made at the very top. Addressing concerns about state sovereignty, the leaders explicitly state that the Pandemic Agreement, and by extension the PABS annex, does not compromise national autonomy. Article 22, paragraph 2, of the Agreement unequivocally affirms that it grants the WHO no authority to direct or alter a country’s laws or policies, nor to mandate measures such as lockdowns, travel restrictions, or vaccination campaigns. These decisions firmly remain within the purview of sovereign states. Leaders are therefore requested to instruct their negotiators to arrive at the July session prepared to conclude, granting them the necessary flexibility to bridge the remaining gaps and finalize the annex.

2. A Spirit of Equity: The PABS system’s efficacy hinges on the equitable distribution of benefits. The "fair bargain" principle means that countries sharing pathogens must trust that the resulting medical countermeasures will also reach their own citizens. Brazil’s G20 presidency in 2024 notably led the G20 to recognize inequality as a significant driver of pandemics, a strategic insight highlighted in the letter. The argument for equity is not merely one of charity or conscience; it is a fundamental strategic imperative. Containing an outbreak at its source through equitable access to tools is far more cost-effective, both in terms of lives and resources, than battling a full-blown global pandemic. As the letter starkly puts it, "A virus left to burn anywhere will, in time, find everyone." Furthermore, equity offers predictability. The current system for pathogen access and benefit-sharing is often improvised during a crisis, leading to uncertainty. PABS aims to establish a single, stable framework of rules, known in advance, allowing laboratories and partners worldwide to respond with the speed an outbreak demands. Legal certainty, the leaders argue, does not compete with equity but enables it. The appeal asks for equity to be embedded in the operational details of the annex, not merely its preamble, ensuring practical guarantees for access and benefit-sharing.

3. A Sense of Urgency: The threat of the next pandemic is not a distant abstraction. Scientists estimate a near one-in-four chance of another pandemic emerging within the coming decade. The landscape of pathogen emergence is shifting dramatically due to climate change, evolving land use patterns, and changes in agriculture. The comforting belief that outbreaks originate only in far-off lands is no longer valid, with future hotspots potentially arising within or near any nation. Simultaneously, rapid advances in biotechnology, often unmatched by adequate biosafety measures, increase the risk of accidental or deliberate release of dangerous agents. These dangers inherently disregard national borders. Therefore, leaders are urged to treat July 17 as an absolute deadline, not a mere milestone, and to publicly declare this commitment, signaling unambiguously to negotiators and the world that this round is the final opportunity to complete the work.

The Staggering Costs of Inaction and the Promise of Preparedness

The price of being unprepared for a pandemic is already well-documented. Beyond the 20 million lives lost to COVID-19 and the $13 trillion economic toll, the ongoing struggle against outbreaks like the current Ebola crisis across two countries—without approved vaccines or cures—serves as a stark reminder. Responders in these regions risk their lives daily, illustrating that such threats are not abstract but immediate realities. Every month the PABS annex remains unfinished is a month the world is less ready, and its people are less safe.

The investment required for a system like PABS, designed to catch outbreaks early, is minuscule compared to the catastrophic costs of a full-scale pandemic response. This proactive approach represents not just a moral imperative but a sound economic and strategic one.

Historical Precedent and the Path Forward

Humanity has a proud history of confronting and overcoming global health challenges through collective action. The eradication of smallpox, the near-elimination of polio, and the significant strides made against HIV, tuberculosis, and malaria stand as testaments to what can be achieved when nations unite. These successes have saved countless lives and reshaped the landscape of global health. Finalizing the Pandemic Agreement, including the PABS annex, is not a departure from this legacy but its natural, essential next chapter. It is a goal that is currently within reach.

The appeal concludes by invoking the memory of the millions lost to COVID-19 and the families who continue to grapple with their absence. President Lula and Dr. Tedros underscore that the current generation bears the responsibility to keep the promise made in that moment of grief: to ensure the world is never again caught unprepared. Finalizing this Agreement through a shared commitment to one another represents a collective promise to protect humanity, one that they urge leaders to fulfill, together and in time.

Implications of Success or Failure

The outcome of the July 6-17 negotiations carries profound implications for global health security, international cooperation, and economic stability.

• Success: A finalized PABS annex would significantly strengthen the global health architecture. It would foster greater trust among nations by embedding equity and transparency into pathogen sharing and benefit distribution. This could lead to faster detection and response times for future outbreaks, potentially saving millions of lives and trillions of dollars. It would also provide legal certainty for researchers and the pharmaceutical industry, encouraging investment in R&D by establishing clear, predictable rules for accessing pathogens and sharing the resulting innovations. This enhanced preparedness would reduce global inequalities in health outcomes and bolster the resilience of national health systems.

• Failure: Should the negotiations fail to finalize the PABS annex, the consequences could be dire. It would erode the fragile trust built during the initial adoption of the Pandemic Agreement and reinforce the perception that global solidarity falters when faced with difficult decisions. Future pandemics would likely be met with the same ad-hoc, nationalistic responses that characterized the early days of COVID-19, leading to continued inequities, exacerbated human suffering, and even greater economic disruption. The absence of a clear framework could also hinder scientific collaboration and innovation, as countries might be less willing to share pathogens without guarantees of equitable access to countermeasures. Such a failure would represent a missed opportunity to learn from recent history and could leave the world dangerously vulnerable to the inevitable next global health crisis, fueling geopolitical friction and undermining faith in multilateral institutions.

As the July 17 deadline approaches, the global community watches intently, hoping that leaders will heed this urgent call and demonstrate the political courage and collaborative spirit required to safeguard humanity’s future.